The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often regarded as outdated and hindering progress, https://marvinvprh714459.wikiadvocate.com/17617/pot_rescheduling_a_growth_catalyst